CD274 and rectal cancer: In the study including 72 patients with rectal cancer after neoCRT, low PD-L1 TPS prior to neoCRT was associated with inferior survival (HR 0.29, 95% CI: 0.11–0.76, p = 0.01) [13], which was similar to our study.